Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,556

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Methicillin-resistant Staphylococcus aureus

Open access
Lee, Andie S., de Lencastre, Hermínia, Garau, Javier, Kluytmans, Jan, Malhotra-Kumar, Surbhi, Peschel, Andreas, Harbarth, Stephan·2018·Nature Reviews Disease Primers
DOI 10.1038/nrdp.2018.33
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrdp.2018.33

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Research works printed but not linked: 229

  1. Becker, K. et al. Staphylococcus aureus from the German general population is highly diverse. Int. J. Med. Microbiol. 307, 21–27 (2017). · DOI
  2. Kuehnert, M. J. et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001–2002. J. Infect. Dis. 193, 172–179 (2006). · DOI · Paper page
  3. Lowy, F. D. Staphylococcus aureus infections. N. Engi J. Med. 339, 520–532 (1998). · DOI · Paper page
  4. Jevons, M. “Celbenin”-resistant staphylococci. BMJ 1, 124–125 (1961). · DOI · Paper page
  5. Dzintars, K. in Kucers’ The Use of Antibiotics (eds Grayson, M. et al.) 136–142 (CRC Press, 2018).
  6. Faoagali, J. L., Thong, M. L. & Grant, D. Ten years’ experience with methicillin-resistant Staphylococcus aureus in a large Australian hospital. J. Hosp. Infect. 20, 113–119 (1992). · doi:10.1016/0195-6701(92)90113-z
  7. Voss, A., Loeffen, F., Bakker, J., Klaassen, C. & Wulf, M. Methicillin-resistant Staphylococcus aureus in pig farming. Emerg. Infect. Dis. 11, 1965–1966 (2005). · DOI · Paper page
  8. Tenover, F. C. et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233–2239 (1995). · DOI · Paper page
  9. Ito, T., Katayama, Y. & Hiramatsu, K. Cloning and nucleotide sequence determination of the entire mec DNA of pre-methicillin-resistant Staphylococcus aureus N315. Antimicrob. Agents Chemother 43, 1449–1458 (1999). · DOI · Paper page
  10. Harkins, C. P. et al. Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome Biol. 18, 130 (2017). · DOI · Paper page
  11. Diekema, D. J. et al. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin. Infect. Dis. 32 (Suppl. 2), S114–S132 (2001). · DOI · Paper page
  12. Enright, M. C., Day, N. P., Davies, C. E., Peacock, S. J. & Spratt, B. G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J. Clin. Microbiol. 38, 1008–1015 (2000). · DOI · Paper page
  13. Monecke, S. et al. A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus. PLoS ONE 6, e17936 (2011). · DOI · Paper page
  14. Kock, R. et al. Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Eurosurveillance 15, 19688 (2010). · DOI · Paper page
  15. Nielsen, K. L. et al. Fitness cost: a bacteriological explanation for the demise of the first international methicillin-resistant Staphylococcus aureus epidemic. J. Antimicrob. Chemother. 67, 1325–1332 (2012). · doi:10.1093/jac/dks051
  16. Rolain, J. M., Abat, C., Brouqui, P. & Raoult, D. Worldwide decrease in methicillin-resistant Staphylococcus aureus: do we understand something? Clin. Microbiol. Infect. 21, 515–517 (2015). · doi:10.1016/j.cmi.2015.04.017
  17. Garcia- Alvarez, L., Dawson, S., Cookson, B. & Hawkey, P. Working across the veterinary and human health sectors. J. Antimicrob. Chemother. 67 (Suppl. 1), Í37–Í49 (2012). · DOI
  18. van Alen, S. et al. In the centre of an epidemic: fifteen years of LA-MRSA CC398 at the University Hospital Munster. Vet. Microbiol. 200, 19–24 (2017). · DOI
  19. Lozano, C. et al. High prevalence of spa types associated with the clonal lineage CC398 among tetracycline-resistant methicillin-resistant Staphylococcus aureus strains in a Spanish hospital. J. Antimicrob. Chemother. 67, 330–334 (2012). · DOI · Paper page
  20. van Cleef, B. A. et al. Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg. Infect. Dis. 17, 502–505 (2011). · DOI · Paper page
  21. Larsen, J. et al. Meticillin-resistant Staphylococcus aureus CC398 is an increasing cause of disease in people with no livestock contact in Denmark, 1999 to 2011. Eurosurveillance 20, 30021 (2015). · DOI
  22. Hetem, D. J., Bootsma, M. C., Troelstra, A. & Bonten, M. J. Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus. Emerg. Infect. Dis. 19, 1797–1802 (2013).
  23. Styers, D., Sheehan, D. J., Hogan, P. & Sahm, D. F. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann. Clin. Microbiol. Antimicrob. 5, 2 (2006). · DOI · Paper page
  24. Talan, D. A. et al. Comparison of Staphylococcus aureus from skin and soft-tissue infections in US emergency department patients, 2004 and 2008. Clin. Infect. Dis. 53, 144–149 (2011). · DOI · Paper page
  25. Seybold, U. et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin. Infect. Dis. 42, 647–656 (2006). · DOI · Paper page
  26. Popovich, K. J., Weinstein, R. A. & Hota, B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin. Infect. Dis. 46, 787–794 (2008). · DOI · Paper page
  27. Planet, P. J. et al. Parallel epidemics of community-associated methicillin-resistant Staphylococcus aureus USA300 infection in North and South America. J. Infect. Dis. 212, 1874–1882 (2015). · DOI
  28. Von Dach, E. et al. Comparative genomics of community-associated methicillin-resistant Staphylococcus aureus shows the emergence of clone ST8-USA300 in Geneva, Switzerland. J. Infect. Dis. 213, 1370–1379 (2016). · DOI
  29. Jain, R. et al. Veterans Affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections. N. Engl. J. Med. 364, 1419–1430 (2011). · DOI · Paper page
  30. Lee, G. M. et al. Effect of nonpayment for preventable infections in U. S. hospitals. N. Engl. J. Med. 367, 1428–1437 (2012). · DOI · Paper page
  31. Chen, C. J. & Huang, Y. C. New epidemiology of Staphylococcus aureus infection in Asia. Clin. Microbiol. Infect. 20, 605–623 (2014). · DOI · Paper page
  32. Mendes, R. E. et al. Regional resistance surveillance program results for 12 Asia-Pacific nations (2011). Antimicrob. Agents Chemother. 57, 5721–5726 (2013). · doi:10.1128/aac.01121-13
  33. Lai, C. C., Lin, S. H., Sheng, W. H. & Hsueh, P. R. Decrease in the incidence of meticillin-resistant Staphylococcus aureus nosocomial bloodstream infections in Taiwan. Int. J. Antimicrob. Agents 41, 591–592 (2013). · DOI
  34. Mitchell, B. G., Collignon, P. J., McCann, R., Wilkinson, I. J. & Wells, A. A major reduction in hospital-onset Staphylococcus aureus bacteremia in Australia-12 years of progress: an observational study. Clin. Infect. Dis. 59, 969–975 (2014). · DOI
  35. Williamson, D. A., Coombs, G. W. & Nimmo, G. R. Staphylococcus aureus ‘Down Under’: contemporary epidemiology of S. aureus in Australia, New Zealand, and the South West Pacific. Clin. Microbiol. Infect. 20, 597–604 (2014). · DOI
  36. Falagas, M. E., Karageorgopoulos, D. E., Leptidis, J. & Korbila, I. P. MRSA in Africa: filling the global map of antimicrobial resistance. PLoS ONE 8, e68024 (2013). · DOI · Paper page
  37. Brink, A., Moolman, J., da Silva, M. C., Botha, M. & National Antibiotic Surveillance Forum. Antimicrobial susceptibility profile of selected bacteraemic pathogens from private institutions in South Africa. S. Afr. Med. J. 97, 273–279 (2007).
  38. Jansen van Rensburg, M. J., Whitelaw, A. C. & Elisha, B. G. Genetic basis of rifampicin resistance in methicillin-resistant Staphylococcus aureus suggests clonal expansion in hospitals in Cape Town, South Africa. BMC Microbiol. 12, 46 (2012). · DOI
  39. Zervou, F. N., Zacharioudakis, I. M., Ziakas, P. D., Rich, J. D. & Mylonakis, E. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus colonization in HIV infection: a meta-analysis. Clin. Infect. Dis. 59, 1302–1311 (2014). · DOI
  40. Kluytmans, J., van Belkum, A. & Verbrugh, H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin. Microbiol. Rev. 10, 505–520 (1997). This is a comprehensive review of staphylococcal nasal colonization including its clinical relevance. · DOI · Paper page
  41. Sim, B. L., McBryde, E., Street, A. C. & Marshall, C. Multiple site surveillance cultures as a predictor of methicillin-resistant Staphylococcus aureus infections. Infect. Control Hosp. Epidemiol. 34, 818–824 (2013). · DOI
  42. Eriksen, N. H., Espersen, F., Rosdahl, V. T. & Jensen, K. Carriage of Staphylococcus aureus among 104 healthy persons during a 19-month period. Epidemiol. Infect. 115, 51–60 (1995). · DOI · Paper page
  43. Hoffler, U., Bulanda, M., Heczko, P. B. & Pulverer, G. A comparison of staphylococcal nasal carrier rates in Germany and Poland. Med. Microbiol. Immunol. 164, 285–290 (1978). · DOI
  44. Emonts, M. et al. Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J. Infect. Dis. 197, 1244–1253 (2008). · DOI
  45. Lucet, J. C. et al. Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. Arch. Intern. Med. 169, 1372–1378 (2009). · doi:10.1001/archinternmed.2009.217
  46. Burian, M. et al. Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization. J. Infect. Dis. 201, 1414–1421 (2010). · DOI
  47. Weidenmaier, C. et al. Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int. J. Med. Microbiol. 298, 505–513 (2008). · DOI
  48. Wertheim, H. F. et al. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med. 5, e17 (2008). · DOI · Paper page
  49. O’Brien, L. M., Walsh, E. J., Massey, R. C., Peacock, S. J. & Foster, T. J. Staphylococcus aureus clumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonization. Cell. Microbiol. 4, 759–770 (2002). · DOI · Paper page
  50. Lemon, K. P. et al. Comparative analyses of the bacterial microbiota of the human nostril and oropharynx. mBio 1, e00129–10 (2010). · DOI · Paper page
  51. Krismer, B. et al. Nutrient limitation governs Staphylococcus aureus metabolism and niche adaptation in the human nose. PLoS Pathog. 10, e1003862 (2014). · DOI · Paper page
  52. Kaspar, U. et al. The culturome of the human nose habitats reveals individual bacterial fingerprint patterns. Environ. Microbiol. 18, 2130–2142 (2016). · DOI · Paper page
  53. Krismer, B., Weidenmaier, C., Zipperer, A. & Peschel, A. The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat. Rev. Microbiol. 15, 675–687 (2017). This review provides a detailed discussion of the complex interplay between S. aureus and other organisms that form part of the nasal microbiota. · DOI · Paper page
  54. Boyle-Vavra, S. et al. USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locus. mBio 6, e02585–14 (2015). · DOI
  55. Spaan, A. N., van Strijp, J. A. G. & Torres, V. J. Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors. Nat. Rev. Microbiol. 15, 435–447 (2017). This is a comprehensive overview of the various pore-forming protein toxins and their cognate host receptors. · DOI · Paper page
  56. Laabei, M. et al. Predicting the virulence of MRSA from its genome sequence. Genome Res. 24, 839–849 (2014). · DOI · Paper page
  57. Thammavongsa, V., Kim, H. K., Missiakas, D. & Schneewind, O. Staphylococcal manipulation of host immune responses. Nat. Rev. Microbiol. 13, 529–543 (2015). · DOI · Paper page
  58. Recker, M. et al. Clonal differences in Staphylococcus aureus bacteraemia-associated mortality. Nat. Microbiol. 2, 1381–1388 (2017). This paper reveals how different S. aureus lineages have adopted different strategies to overcome host responses and cause severe pathology. · DOI
  59. Kluytmans, J. A. et al. Nasal carriage of Staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J. Infect. Dis. 171, 216–219 (1995). · DOI · Paper page
  60. Foster, T. J., Geoghegan, J. A., Ganesh, V. K. & Hook, M. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat. Rev. Microbiol. 12, 49–62 (2014). · DOI · Paper page
  61. Vanhommerig, E. et al. Comparison of biofilm formation between major clonal lineages of methicillin resistant Staphylococcus aureus. PLoS ONE 9, e104561 (2014). · DOI
  62. Spaan, A. N., Surewaard, B. G., Nijland, R. & van Strijp, J. A. Neutrophils versus Staphylococcus aureus: a biological tug of war. Annu. Rev. Microbiol. 67, 629–650 (2013). · DOI · Paper page
  63. Hanzelmann, D. et al. Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants. Nat. Commun. 7, 12304 (2016). · DOI
  64. Cheng, A. G., DeDent, A. C., Schneewind, O. & Missiakas, D. A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol. 19, 225–232 (2011). · DOI · Paper page
  65. Laarman, A., Milder, F., van Strijp, J. & Rooijakkers, S. Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications. J. Mol. Med. 88, 115–120 (2010). · DOI
  66. Stapels, D. A. et al. Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors. Proc. Natl Acad. Sci. USA 111, 13187–13192 (2014). · DOI
  67. Peschel, A. & Sahl, H. G. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4, 529–536 (2006). · DOI · Paper page
  68. Loffler, B. et al. Staphylococcus aureus panton–valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog. 6, e1000715 (2010). · DOI · Paper page
  69. Spaulding, A. R. et al. Staphylococcal and streptococcal superantigen exotoxins. Clin. Microbiol. Rev. 26, 422–447 (2013). · DOI · Paper page
  70. Chavakis, T., Wiechmann, K., Preissner, K. T. & Herrmann, M. Staphylococcus aureus interactions with the endothelium: the role of bacterial “secretable expanded repertoire adhesive molecules” (SERAM) in disturbing host defense systems. Thromb. Haemost. 94, 278–285 (2005). · DOI · Paper page
  71. Weidenmaier, C. et al. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J. Infect. Dis. 191, 1771–1777 (2005). · DOI · Paper page
  72. Loffler, B., Tuchscherr, L., Niemann, S. & Peters, G. Staphylococcus aureus persistence in non-professional phagocytes. Int. J. Med. Microbiol. 304, 170–176 (2014). · DOI
  73. Thomer, L., Schneewind, O. & Missiakas, D. Pathogenesis of Staphylococcus aureus bloodstream infections. Annu. Rev. Pathol. 11, 343–364 (2016). · DOI · Paper page
  74. Le, K. Y. & Otto, M. Quorum-sensing regulation in staphylococci-an overview. Front. Microbiol. 6, 1174 (2015).
  75. Cheung, G. Y., Wang, R., Khan, B. A., Sturdevant, D. E. & Otto, M. Role of the accessory gene regulator agr in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. Infect. Immun. 79, 1927–1935 (2011). · DOI · Paper page
  76. Kaito, C. et al. Mobile genetic element SCCmec-encoded psm-mec RNA suppresses translation of agrA and attenuates MRSA virulence. PLoS Pathog. 9, e1003269 (2013). · DOI
  77. Painter, K. L., Krishna, A., Wigneshweraraj, S. & Edwards, A. M. What role does the quorum-sensing accessory gene regulator system play during Staphylococcus aureus bacteremia? Trends Microbiol. 22, 676–685 (2014). · DOI
  78. Crisostomo, M. I. et al. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc. Natl Acad. Sci. USA 98, 9865–9870 (2001). · DOI · Paper page
  79. International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob. Agents Chemother. 53, 4961–4967 (2009). This paper describes the main SCCmec types and the nomenclature to be followed for the naming of new SCCmec types. · DOI · Paper page
  80. Bal, A. M. et al. Genomic insights into the emergence and spread of international clones of healthcare-, community- and livestock-associated meticillin-resistant Staphylococcus aureus: Blurring of the traditional definitions. J. Glob. Antimicrob. Resist 6, 95–101 (2016). · DOI
  81. Hartman, B. J. & Tomasz, A. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J. Bacteriol. 158, 513–516 (1984). · DOI · Paper page
  82. Garcia-Alvarez, L. et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect. Dis. 11, 595–603 (2011). · DOI · Paper page
  83. Kim, C. et al. Properties of a novel PBP2A protein homolog from Staphylococcus aureus strain LGA251 and its contribution to the beta-lactam-resistant phenotype. J. Biol. Chem. 287, 36854–36863 (2012). · doi:10.1074/jbc.m112.395962
  84. Milheirico, C., de Lencastre, H. & Tomasz, A. Full-genome sequencing identifies in the genetic background several determinants that modulate the resistance phenotype in methicillin-resistant Staphylococcus aureus strains carrying the novel mecC gene. Antimicrob. Agents Chemother. 61, e02500–16 (2017). · doi:10.1128/aac.02500-16
  85. Becker, K. et al. Plasmid-encoded transferable mecB-mediated methicillin resistance in Staphylococcus aureus. Emerg. Infect. Dis. 24, 242–248 (2018). · DOI · Paper page
  86. Hiramatsu, K., Asada, K., Suzuki, E., Okonogi, K. & Yokota, T. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBSLett. 298, 133–136 (1992). · DOI · Paper page
  87. Arede, P., Milheirico, C., de Lencastre, H. & Oliveira, D. C. The anti-repressor MecR2 promotes the proteolysis of the mecA repressor and enables optimal expression of beta-lactam resistance in MRSA. PLoS Pathog. 8, e1002816 (2012). · DOI
  88. Zhang, H. Z., Hackbarth, C. J., Chansky, K. M. & ≈Chambers, H. F. A proteolytic transmembrane signaling pathway and resistance to beta-lactams in staphylococci. Science 291, 1962–1965 (2001). · DOI · Paper page
  89. De Lencastre, H. et al. Antibiotic resistance as a stress response: complete sequencing of a large number of chromosomal loci in Staphylococcus aureus strain COL that impact on the expression of resistance to methicillin. Microb. Drug Resist 5, 163–175 (1999). · DOI
  90. Kim, C. et al. The mechanism of heterogeneous beta-lactam resistance in MRSA: key role of the stringent stress response. PLoS ONE 8, e82814 (2013). · DOI
  91. Boyle-Vavra, S., Yin, S. & Daum, R. S. The VraS/VraR two-component regulatory system required for oxacillin resistance in community-acquired methicillin-resistant Staphylococcus aureus. FEMS Microbiol. Lett. 262, 163–171 (2006). · DOI
  92. Jousselin, A. et al. The Staphylococcus aureus chaperone PrsA is a new auxiliary factor of oxacillin resistance affecting penicillin-binding protein 2A. Antimicrob. Agents Chemother 60, 1656–1666 (2015). · DOI
  93. Kim, C. K., Milheirico, C., de Lencastre, H. & Tomasz, A. Antibiotic resistance as a stress response: recovery of high-level oxacillin resistance in methicillin-resistant Staphylococcus aureus “Auxiliary” (fem) mutants by induction of the stringent stress response. Antimicrob. Agents Chemother 61, e00313-17 (2017). · doi:10.1128/aac.00313-17
  94. Epstein, L. et al. Risk factors for invasive methicillin-resistant Staphylococcus aureus infection after recent discharge from an acute-care hospitalization, 2011–2013. Clin. Infect. Dis. 62, 45–52 (2016). · DOI · Paper page
  95. Davis, K. A., Stewart, J. J., Crouch, H. K., Florez, C. E. & Hospenthal, D. R. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin. Infect. Dis. 39, 776–782 (2004). · DOI · Paper page
  96. Francis, J. S. et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton–Valentine leukocidin genes. Clin. Infect. Dis. 40, 100–107 (2005). · DOI · Paper page
  97. Kazakova, S. V. et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N. Engl. J. Med. 352, 468–475 (2005). · DOI · Paper page
  98. Aiello, A. E., Lowy, F. D., Wright, L. N. & Larson, E. L. Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect. Dis. 6, 335–341 (2006). · DOI
  99. Drougka, E. et al. A 12-year survey of methicillin-resistant Staphylococcus aureus infections in Greece: ST80-IV epidemic? Clin. Microbiol. Infect. 20, O796–803 (2014). · DOI
  100. Ryffel, C., Strassle, A., Kayser, F. H. & Berger-Bachi, B. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 38, 724–728 (1994). · DOI
  101. Penn, C. et al. Wound infections caused by inducible meticillin-resistant Staphylococcus aureus strains. J. Glob. Antimicrob. Resist 1, 79–83 (2013). · doi:10.1016/j.jgar.2013.03.009
  102. Winstanley, T. & Courvalin, P. Expert systems in clinical microbiology. Clin. Microbiol. Rev. 24, 515–556 (2011). This reference is a good overview of automated systems for the detection of resistance mechanisms with a critical review of published evaluations of the performance of each system. · DOI
  103. Bhowmick, T. et al. Controlled multicenter evaluation of a bacteriophage-based method for rapid detection of Staphylococcus aureus in positive blood cultures. J. Clin. Microbiol. 51, 1226–1230 (2013). · DOI
  104. Opota, O., Croxatto, A., Prod’hom, G. & Greub, G. Blood culture-based diagnosis of bacteraemia: state of the art. Clin. Microbiol. Infect. 21, 313–322 (2015). · DOI · Paper page
  105. Romero-Gomez, M. P., Cendejas-Bueno, E., Garcia Rodriguez, J. & Mingorance, J. Impact of rapid diagnosis of Staphylococcus aureus bacteremia from positive blood cultures on patient management. Eur. J. Clin. Microbiol. Infect. Dis. 36, 2469–2473 (2017). · DOI
  106. Malhotra-Kumar, S. et al. Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J. Clin. Microbiol. 46, 1577–1587 (2008). · DOI
  107. Malhotra- Kumar, S. et al. Evaluation of molecular assays for rapid detection of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 48, 4598–4601 (2010). · doi:10.1128/jcm.00004-10
  108. Blaschke, A. J. et al. Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagnost. Microbiol. Infect. Dis. 74, 349–355 (2012). · DOI · Paper page
  109. Almuhayawi, M., Altun, O., Stralin, K. & Ozenci, V. Identification of microorganisms by FilmArray and matrix-assisted laser desorption ionization-time of flight mass spectrometry prior to positivity in the blood culture system. J. Clin. Microbiol. 52, 3230–3236 (2014). · DOI
  110. Cao, M. D. et al. Streaming algorithms for identification of pathogens and antibiotic resistance potential from real-time MinION(TM) sequencing. GigaScience 5, 32 (2016). · DOI
  111. Aanensen, D. M. et al. Whole-genome sequencing for routine pathogen surveillance in public health: a population snapshot of invasive Staphylococcus aureus in Europe. mBio 7, e00444-16 (2016). · DOI · Paper page
  112. Koser, C. U. et al. Rapid whole-genome sequencing for investigation of a neonatal MRSA outbreak. N. Engl. J. Med. 366, 2267–2275 (2012). · DOI · Paper page
  113. Millar, E. V. et al. Genomic characterization of USA300 methicillin-resistant Staphylococcus aureus (MRSA) to evaluate intraclass transmission and recurrence of skin and soft tissue infection (SSTI) among high-risk military trainees. Clin. Infect. Dis. 65, 461–468 (2017). · doi:10.1093/cid/cix327
  114. Merlino, J., Leroi, M., Bradbury, R., Veal, D. & Harbour, C. New chromogenic identification and detection of Staphylococcus aureus and methicillin-resistant S. aureus. J. Clin. Microbiol. 38, 2378–2380 (2000). · doi:10.1128/jcm.38.6.2378-2380.2000
  115. Perry, J. D. A. Decade of development of chromogenic culture media for clinical microbiology in an era of molecular diagnostics. Clin. Microbiol. Rev. 30, 449–479 (2017). Tqhis is a comprehensive reference reviewing rapid culture methods for the detection of MRSA and other multidrug-resistant organisms. · DOI · Paper page
  116. Gazin, M. et al. Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study. Eur. J. Clin. Microbiol. Infect. Dis. 31, 1765–1770 (2012). · doi:10.1007/s10096-011-1499-0
  117. Luthje, P. et al. Identification of microorganisms grown on chromogenic media by MALDI-TOF MS. J. Microbiol. Methods 136, 17–20 (2017). · doi:10.1016/j.mimet.2017.03.001
  118. Faron, M. L. et al. Automated scoring of chromogenic media for detection of methicillin-resistant Staphylococcus aureus by use of WASPLab image analysis software. J. Clin. Microbiol. 54, 620–624 (2016). · DOI · Paper page
  119. Cunningham, R. et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J. Hosp. Infect. 65, 24–28 (2007). · doi:10.1016/j.jhin.2006.09.019
  120. Derde, L. P. G. et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect. Dis. 14, 31–39 (2014). · DOI · Paper page
  121. Wu, P. J., Jeyaratnam, D., Tosas, O., Cooper, B. S. & French, G. L. Point-of-care universal screening for meticillin-resistant Staphylococcus aureus: a cluster-randomized cross-over trial. J. Hosp. Infect. 95, 245–252 (2017). · doi:10.1016/j.jhin.2016.08.017
  122. Calfee, D. P. et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect. Control Hosp. Epidemiol. 35, 772–796 (2014). This paper is an expert guidance document, with grading of the quality of the evidence, for MRSA control in acute care facilities. · DOI · Paper page
  123. World Health Organization. WHO Guidelines on Hand Hygiene in Health Care. World Alliance for Patient Safety (WHO Press, Geneva, 2009).
  124. Sax, H. et al. ‘My five moments for hand hygiene’: a user-centred design approach to understand, train, monitor and report hand hygiene. J. Hosp. Infect. 67, 9–21 (2007). · DOI · Paper page
  125. Stone, S. P. et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ 344, e3005 (2012). · DOI · Paper page
  126. Salgado, C. D. & Farr, B. M. What proportion of hospital patients colonized with methicillin-resistant Staphylococcus aureus are identified by clinical microbiological cultures? Infect. Control Hosp. Epidemiol. 27, 116–121 (2006). · DOI
  127. Robicsek, A. et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann. Intern. Med. 148, 409–418 (2008). · DOI · Paper page
  128. Harbarth, S. et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 299, 1149–1157 (2008). · DOI · Paper page
  129. Lee, A. S. et al. Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ Open 3, e003126 (2013). · DOI
  130. Robotham, J. V. et al. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study. Lancet Infect. Dis. 16, 348–356 (2016). · doi:10.1016/s1473-3099(15)00417-x
  131. Huskins, W. C. et al. Intervention to reduce transmission of resistant bacteria in intensive care. N. Engl. J. Med. 364, 1407–1418 (2011). · DOI · Paper page
  132. Derde, L. P. et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial. Lancet Infect. Dis. 14, 31–39 (2014). · DOI · Paper page
  133. Harris, A. D. et al. Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial. JAMA 310, 1571–1580 (2013).
  134. Cepeda, J. A. et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 365, 295–304 (2005). · DOI · Paper page
  135. Fatkenheuer, G., Hirschel, B. & Harbarth, S. Screening and isolation to control meticillin-resistant Staphylococcus aureus: sense, nonsense, and evidence. Lancet 385, 1146–1149 (2015). This commentary provides an update regarding the growing evidence for and against the role of active surveillance in MRSA control. · doi:10.1016/s0140-6736(14)60660-7
  136. Loeb, M., Main, C., Walker-Dilks, C. & Eady, A. Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization. Cochrane Database Syst. Rev. 4, CD003340 (2003).
  137. Poovelikunnel, T., Gethin, G. & Humphreys, H. Mupirocin resistance: clinical implications and potential alternatives for the eradication of MRSA. J. Antimicrob. Chemother. 70, 2681–2692 (2015). · DOI · Paper page
  138. Landelle, C. et al. Randomized, placebo-controlled, double-blind clinical trial to evaluate the efficacy of polyhexanide for topical decolonization of MRSA carriers. J. Antimicrob. Chemother. 71, 531–538 (2016). · DOI
  139. Bode, L. G. et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N. Engl. J. Med. 362, 9–17 (2010). · DOI · Paper page
  140. van Rijen, M. M., Bode, L. G., Baak, D. A., Kluytmans, J. A. & Vos, M. C. Reduced costs for Staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopaedic surgery. PLoS ONE 7, e43065 (2012). · DOI
  141. Huang, S. S. et al. Targeted versus universal decolonization to prevent ICU infection. N. Engl. J. Med. 368, 2255–2265 (2013). · DOI · Paper page
  142. Ammerlaan, H. S. et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline. J. Antimicrob. Chemother. 66, 2409–2417 (2011). · DOI
  143. Ammerlaan, H. S. et al. Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure. J. Antimicrob. Chemother. 66, 2418–2424 (2011). · doi:10.1093/jac/dkr250
  144. Talan, D. A. et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N. Engl. J. Med. 374, 823–832 (2016). · DOI · Paper page
  145. Daum, R. S. et al. A placebo-controlled trial of antibiotics for smaller skin abscesses. N. Engl. J. Med. 376, 2545–2555 (2017). · DOI · Paper page
  146. Liu, C. et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin. Infect. Dis. 52, e18–55 (2011). This paper represents an essential and up-to-date guidance document for management of MRSA infection. · DOI · Paper page
  147. Gould, I. M. et al. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance. Int. J. Antimicrob. Agents 39, 96–104 (2012). · DOI · Paper page
  148. Svetitsky, S., Leibovici, L. & Paul, M. Comparative efficacy and safety of vancomycin versus teicoplanin: systematic review and meta-analysis. Antimicrob. Agents Chemother. 53, 4069–4079 (2009). · DOI · Paper page
  149. Vandecasteele, S. J., De Vriese, A. S. & Tacconelli, E. The pharmacokinetics and pharmacodynamics of vancomycin in clinical practice: evidence and uncertainties. J. Antimicrob. Chemother. 68, 743–748 (2013). · DOI
  150. Lodise, T. P., Patel, N., Lomaestro, B. M., Rodvold, K. A. & Drusano, G. L. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin. Infect. Dis. 49, 507–514 (2009). · DOI · Paper page
  151. Cataldo, M. A., Tacconelli, E., Grilli, E., Pea, F. & Petrosillo, N. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J. Antimicrob. Chemother. 67, 17–24 (2012). · DOI · Paper page
  152. Bradley, J. S. Which antibiotic for resistant Gram-positives, and why? J. Infect. 68 (Suppl. 1), S63–75 (2014). · DOI
  153. Falagas, M. E. & Vardakas, K. Z. Benefit-risk assessment of linezolid for serious gram-positive bacterial infections. DrugSaf. 31, 753–768 (2008).
  154. Cosgrove, S. E. et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin. Infect. Dis. 36, 53–59 (2003). · DOI · Paper page
  155. Fowler, V. G. Jr. et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch. Intern. Med. 163, 2066–2072 (2003). · DOI · Paper page
  156. Thwaites, G. E. et al. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect. Dis. 11, 208–222 (2011). This is an important reference for all persons interested in the optimal treatment of S. aureus bacteraemia. · DOI · Paper page
  157. Houlihan, H. H., Mercier, R. C. & Rybak, M. J. Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. Antimicrob. Agents Chemother. 41, 2497–2501 (1997). · doi:10.1128/aac.41.11.2497
  158. Tsuji, B. T. & Rybak, M. J. Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob. Agents Chemother. 49, 2735–2745 (2005). · DOI
  159. Rehm, S. J. et al. Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolates. J. Antimicrob. Chemother. 62, 1413–1421 (2008). · DOI
  160. Fowler, V. G. Jr. et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N. Engl. J. Med. 355, 653–665 (2006). · DOI · Paper page
  161. Bayer, A. S. & Murray, B. E. Initial low-dose aminoglycosides in Staphylococcus aureus bacteremia: good science, urban legend, or just plain toxic? Clin. Infect. Dis. 48, 722–724 (2009). · DOI
  162. Forrest, G. N. & Tamura, K. Rifampin combination therapy for nonmycobacterial infections. Clin. Microbiol. Rev. 23, 14–34 (2010). · DOI · Paper page
  163. Thwaites, G. E. et al. Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 391, 668–678 (2018). · DOI · Paper page
  164. Davis, J. S. et al. Combination of vancomycin and beta-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial. Clin. Infect. Dis. 62, 173–180 (2016). · DOI · Paper page
  165. Sakoulas, G. et al. Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline. Clin. Ther. 36, 1317–1333 (2014). · DOI · Paper page
  166. Rose, W. E., Berti, A. D., Hatch, J. B. & Maki, D. G. Relationship of in vitro synergy and treatment outcome with daptomycin plus rifampin in patients with invasive methicillin-resistant Staphylococcus aureus infections. Antimicrob. Agents Chemother. 57, 3450–3452 (2013). · DOI
  167. Cosimi, R. A., Beik, N., Kubiak, D. W. & Johnson, J. A. Ceftaroline for severe methicillin-resistant Staphylococcus aureus infections: a systematic review. Open Forum Infect. Dis. 4, ofx084 (2017). · DOI
  168. Tattevin, P., Basuino, L., Bauer, D., Diep, B. A. & Chambers, H. F. Ceftobiprole is superior to vancomycin, daptomycin, and linezolid for treatment of experimental endocarditis in rabbits caused by methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 54, 610–613 (2010). · DOI
  169. Oltolini, C. et al. Meticillin-resistant Staphylococcus aureus endocarditis: first report of daptomycin plus ceftobiprole combination as salvage therapy. Int. J. Antimicrob. Agents 47, 502–504 (2016). · DOI
  170. Andrey, D. O. et al. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013–2014 at the Geneva University Hospitals. Eur. J. Clin. Microbiol. Infect. Dis. 36, 343–350 (2017). · doi:10.1007/s10096-016-2807-5
  171. Long, S. W. et al. PBP2a mutations causing high-level Ceftaroline resistance in clinical methicillin-resistant Staphylococcus aureus isolates. Antimicrob. Agents Chemother. 58, 6668–6674 (2014). · DOI
  172. Mendes, R. E. et al. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline. J. Antimicrob. Chemother. 67, 1321–1324 (2012). · doi:10.1093/jac/dks069
  173. Zhanel, G. G. et al. New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin. Drugs 70, 859–886 (2010). · DOI · Paper page
  174. McCurdy, S. P., Jones, R. N., Mendes, R. E., Puttagunta, S. & Dunne, M. W. In vitro activity of dalbavancin against drug-resistant Staphylococcus aureus isolates from a global surveillance program. Antimicrob. Agents Chemother. 59, 5007–5009 (2015). · DOI
  175. Werth, B. J. et al. Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen. Clin. Microbiol. Infect. 24, 429.e1–429.e5 (2018). · DOI
  176. Yaw, L. K., Robinson, J. O. & Ho, K. M. A comparison of long-term outcomes after meticillin-resistant and meticillin-sensitive Staphylococcus aureus bacteraemia: an observational cohort study. Lancet Infect. Dis. 14, 967–975 (2014). · DOI
  177. Fatkenheuer, G. & Kaasch, A. J. How deadly is meticillin-resistant Staphylococcus aureus? Lancet Infect. Dis. 14, 905–907 (2014).
  178. De Angelis, G. et al. Multistate modelling to estimate the excess length of stay associated with meticillin-resistant Staphylococcus aureus colonisation and infection in surgical patients. J. Hosp. Infect. 78, 86–91 (2011). · DOI
  179. De Angelis, G., Murthy, A., Beyersmann, J. & Harbarth, S. Estimating the impact of healthcare-associated infections on length of stay and costs. Clin. Microbiol. Infect. 16, 1729–1735 (2010). · doi:10.1111/j.1469-0691.2010.03332.x
  180. Stewardson, A. J. et al. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study. Eurosurveillance 21, 30319 (2016). This is a methodologically sound analysis of excess length of stay of MRSA bacteraemia. · DOI · Paper page
  181. Haessler, S., Mackenzie, T. & Kirkland, K. B. Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus. J. Hosp. Infect. 69, 39–45 (2008). · doi:10.1016/j.jhin.2008.01.008
  182. Pendleton, A. & Kocher, M. S. Methicillin-resistant Staphylococcus aureus bone and joint infections in children. J. Am. Acad. Orthop. Surg. 23, 29–37 (2015). · DOI
  183. Salgado, C. D., Dash, S., Cantey, J. R. & Marculescu, C. E. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin. Orthop. Relat. Res. 461, 48–53 (2007). · DOI · Paper page
  184. Gleeson, A., Larkin, P. & O'Sullivan, N. The impact of meticillin-resistant Staphylococcus aureus on patients with advanced cancer and their family members: a qualitative study. Palliat. Med. 30, 382–391 (2016). · DOI
  185. van Cleef, B. A. et al. Health and health-related quality of life in pig farmers carrying livestock-associated methicillin-resistant Staphylococcus aureus. Epidemiol. Infect. 144, 1774–1783 (2016). · DOI
  186. Ammerlaan, H. S. et al. Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin. Infect. Dis. 56, 798–805 (2013). This is most likely the best paper evaluating the question of whether MRSA adds to the overall burden of nosocomial infections. · DOI · Paper page
  187. Jones, B. E. et al. Variation in empiric coverage versus detection of methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in hospitalizations for community-onset pneumonia across 128 US veterans affairs medical centers. Infect. Control Hosp. Epidemiol. 38, 937–944 (2017). · DOI
  188. Herr, C. E., Heckrodt, T. H., Hofmann, F. A., Schnettler, R. & Eikmann, T. F. Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward. Infect. Control Hosp. Epidemiol. 24, 673–678 (2003). · doi:10.1086/502274
  189. Wertheim, H. F. et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364, 703–705 (2004). · DOI · Paper page
  190. Pozzi, C. et al. Vaccines for Staphylococcus aureus and target populations. Curr. Top. Microbiol. Immunol. 409, 491–528 (2017).
  191. Fowler, V. G. et al. Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. JAMA 309, 1368–1378 (2013). · DOI · Paper page
  192. Shinefield, H. et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med. 346, 491–496 (2002). · DOI · Paper page
  193. Stentzel, S. et al. Specific serum IgG at diagnosis of Staphylococcus aureus bloodstream invasion is correlated with disease progression. J. Proteom. 128, 1–7 (2015). · DOI
  194. Kurokawa, K., Takahashi, K. & Lee, B. L. The staphylococcal surface-glycopolymer wall teichoic acid (WTA) is crucial for complement activation and immunological defense against Staphylococcus aureus infection. Immunobiology 221, 1091–1101 (2016). · DOI
  195. Bekeredjian-Ding, I. Deciphering the significance of the T cell response to Staphylococcus aureus. Future Microbiol. 12, 1023–1026 (2017). · doi:10.2217/fmb-2017-0138
  196. Idelevich, E. A. et al. In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin. Antimicrob. Agents Chemother. 55, 4416–4419 (2011). · DOI
  197. Hiramatsu, K. et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40, 135–136 (1997). · DOI · Paper page
  198. Mwangi, M. M. et al. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl Acad. Sci. USA 104, 9451–9456 (2007). · DOI · Paper page
  199. Khatib, R. et al. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia. J. Antimicrob. Chemother. 66, 1594–1599 (2011). · DOI
  200. Satola, S. W. et al. Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. aureus phenotype. J. Clin. Microbiol. 49, 1583–1587 (2011). · DOI

200 of 229 shown

Cited by

See all 1,556

Metadata

Authors
Lee, A. S., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S.
Venue
Nature Reviews Disease Primers
Publisher
Springer Science and Business Media LLC
Published
2018-05-31
Volume
4
Issue
1
Pages
18033-18033
ISSN
2056-676X (ISSN-L)
DOI
10.1038/nrdp.2018.33
OpenAlex
W2312720395
Cited by
1,556
References
18
FWCI
15.12
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methicillin-resistant Staphylococcus aureus. https://app.cochat.ai/papers/10.1038/nrdp.2018.33
The paper
Lee, A. S., de Lencastre, H., Garau, J., Kluytmans, J., Malhotra-Kumar, S., Peschel, A., & Harbarth, S. (2018). Methicillin-resistant Staphylococcus aureus. Nature Reviews Disease Primers. https://doi.org/10.1038/nrdp.2018.33

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.